R&D head retires after 19 years at ALK: "We created the modern ALK"
After two decades at the R&D helm, the allergy firm presented Henrik Jacobi’s replacement on Wednesday. ”We’re still pioneers but we are far less biotech in the way we think now than back then,” he says.
by mikkel aabenhus hemmingsen, translated by daniel pedersen
22 years at ALK – 19 of which were spent leading the company’s research and development efforts – is coming to an end for Henrik Jacobi. In March next year, he entrusts his responsibilities to Henriette Mersebach, who has been hired as his replacement.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
ALK loses R&D exec, finds Novo Nordisk replacement
For subscribers
ALK CFO to step down
For subscribers
